Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Clinical trial NCT02291237 · TERMINATED
Trial details
- NCT number
- NCT02291237
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-05
- Primary completion
- 2017-01-20
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.